In an international study of 1,635 emergency-department patients, urinary neutrophil gelatinase-associated lipocalin (uNGAL) was the most useful of five urinary biomarkers in predicting the severity and duration of acute kidney injury (AKI) at the time of hospital admission, with 81% specificity and 68% sensitivity at a cutoff of 104 ng/mL.
In the study by Thomas L. Nickolas, MD, MS, and colleagues, which was published in the Journal of the American College of Cardiology (2012;59:246-255), uNGAL and another biomarker, urinary kidney injury molecule 1, predicted a composite outcome of dialysis initiation or death during hospitalization, improved the net risk classification compared with conventional assessments, and identified a substantial subpopulation of patients who had low serum creatinine at hospital admission but were at risk of adverse events.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.